M. Emmy M. Dolman - Concepedia

Author

M. Emmy M. Dolman

Also Known As

Dolman, Mark, Emmy Dolman, Emmy M Dolman, Emmy M. Dolman, Emmy M. Dolman (21786712), M Dolman, M Emmy Dolman, M Emmy M Dolman, M. E. (Emmy) M. Dolman, M. E. M. Dolman

124

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Princess Máxima Center Utrecht University Amsterdam UMC Location University of Amsterdam University of Amsterdam German Cancer Research Center

About

M. Emmy M. Dolman is an author at Princess Máxima Center specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	1.4K
2	Natural Sciences	3	3	74
3	Biochemistry	3	3	87
4	Biomolecular Engineering	2	2	58
5	Engineering	1	1	38

M. Emmy M. Dolman

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations Thomas F. Eleveld, Derek A. Oldridge, Virginie Bernard, Nature Genetics Receptor Tyrosine KinasePathologyNeuroblastsTumor SuppressorCancer Genetics	2015	543
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer Marie Wong, Chelsea Mayoh, Loretta M. S. Lau, Nature Medicine Functional GenomicsHigh-risk Pediatric CancerMedicineEpigenetic ChangeEpigenomics	2020	372
An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity Camilla Calandrini, Frans Schutgens, Rurika Oka, Nature Communications	2020	301
TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets Bieke Decaesteker, Geertrui Denecker, Christophe Van Neste, Nature Communications	2018	108
Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma Sally L. George, Federica Lorenzi, David S. King, EBioMedicine	2020	76
Newly-derived neuroblastoma cell lines propagated in serum-free media recapitulate the genotype and phenotype of primary neuroblastoma tumours Laurel T. Bate-Eya, Marli E. Ebus, Jan Köster, European Journal of Cancer Tumor BiologyPrimary Neuroblastoma TumoursTumor InnervationPathologyNeuroblasts	2013	67
Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma M. Emmy M. Dolman, Evon Poon, Marli E. Ebus, Clinical Cancer Research	2015	67
High efficacy of the BCL-2 inhibitor ABT199 (venetoclax) in BCL-2 high-expressing neuroblastoma cell lines and xenografts and rational for combination with MCL-1 inhibition Laurel T. Bate-Eya, Ilona J.M. den Hartog, Ida van der Ploeg, Oncotarget	2016	60
Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumors Camilla Calandrini, Sander R. van Hooff, Irene Paassen, Cell Reports	2021	57
Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes Michael T. Meister, Marian J.A. Groot Koerkamp, Terezinha de Souza, EMBO Molecular Medicine Tumor HeterogeneityPathologyRhabdomyosarcoma SubtypesMedicineTumor Biology	2022	52

Page 1